As previously described and according to the diabetes diagnostic criteria from American Diabetes Association (ADA), participants can be identified as diabetes by the following criteria, including self-reported diagnosis, use of insulin or oral hypoglycemic medication, FBG 126 mg/dL or HbA1c level 6.5% [30, 31]
Formichi C, Baronti W, de Gennaro G, Cerrai Ceroni M, Nigi L, Rizzo L, et al
So-called GLP-1 supplements, named to echo the class of glucagon-like peptide-1 agonist drugs that includes Wegovy and Zepbound, are likely to be ineffective for weight loss
The cost of ShedRx may be a deciding factor for individuals considering these medications, but the benefits, including improved energy levels and lifestyle changes, may outweigh the cost for some users